REUTERS
November 10, 2021 at 14:50 JST
Pfizer Inc.'s novel coronavirus vaccine (Asahi Shimbun file photo)
Pfizer Inc. has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.
Pfizer's Comirnaty vaccine, developed in partnership with BioNTech, was the first COVID-19 vaccine approved for Japan's general public in February. COVID-19 vaccines developed by Moderna and AstraZeneca have since been approved.
Pfizer's vaccine is currently being offered to those aged 12 and above. If approved by the health ministry, it will be the first to be administered to children under 11 in Japan.
About 74% of the population is now fully vaccinated, according to broadcaster NHK, and the government is widely expected to start administering booster shots by year-end.
New Zealand reports first death linked to Pfizer COVID-19 vaccine
August 30, 2021
Syringe mix-up to hurt efficiency in COVID-19 vaccine program
February 10, 2021
Pfizer agreed to supply additional COVID-19 vaccines, says Japan’s vaccine minister
April 18, 2021
Kono: Japan secures sufficient supply for Pfizer booster shots
August 17, 2021
AstraZeneca to make 90 million COVID-19 doses in Japan
January 28, 2021
Japan receives first batch of COVID-19 vaccine, courtesy of Pfizer
February 12, 2021
Here is a collection of first-hand accounts by “hibakusha” atomic bomb survivors.
A peek through the music industry’s curtain at the producers who harnessed social media to help their idols go global.
Cooking experts, chefs and others involved in the field of food introduce their special recipes intertwined with their paths in life.
A series based on diplomatic documents declassified by Japan’s Foreign Ministry
A series about Japanese-Americans and their memories of World War II
